Abstract: Influenza virus affects the respiratory tract in humans causing a range of distinct manifestations including fever, nasal secretions, cough, headaches, muscle pain and pneumonia, which could become violent and severe. It was found that influenza A viruses remain resistant to amantadine and rimantadin with high level of oseltamvir resistance. Therefore, there is a need for constant improvement of drugs active against resistant influenza viruses. Propolis has anti-influenza activity both in vitro and in vivo. Human leukocyte interferon (HuIFN-αN3) is a multi-subtype protein that displays an antiviral activity against influenza virus. In this study we elucidated the anti-influenza activity of the mixes of water-soluble propolis (WSP) (Greit 120) and HuIFN-αN3 at different ratios. Greit 120 polyphenols, total phenol acids and bioflavonoid were characterized by HPLC-UV-ESI-MS504971 and HuIFN-αN3 by reverse-phase high-performance liquid chromatography (RP-HPLC). Influenza A and B viruses were separately added to the LLC-MK2 cells treated with WSP (Greit 120) and HuIFN-αN3 alone or in proportions 1:1, 1:2 and 2:1. Plates were incubated and cytopathic effect was determined. The best results (ID 50 ) were obtained with the mix of 10% WSP and HuIFN-αN3 in proportion 1:2, showing ID 50 at 12 ± 0.2 µg/mL and 19 ± 0.6 µg/mL for influenza A and B viruses, respectively. When comparing anti-influenza activity of WSP (Greit 120)/HuIFN-αN3 with that of ribavirin, it was found that 1:2 was the optimal ratio for WSP (Greit 120)/HuIFN-αN3 (0.5 and 0.6 for influenza A and B, respectively). This new formulation of WSP (Greit 120) and HuIFN-αN3, showing better anti-Influenza activity, will definitely improve its application in flu infections.
Introduction
 Influenza virus affects the respiratory tract in humans and animals leading to a range of diverse symptoms, consisting of fever, nasal secretions, cough, headache, muscle pain and pneumonia which usually could become severe [1, 2] . During influenza season, antigenic drift in the virus usually appears when the design of the year's vaccine was then established. Therefore, the vaccine became less protective and outbreaks occur [3] . The pandemic avian H5N1 and H1N1 and then changed influenza virus A (H3N2) strains have expanded worldwide, so the emergence of D DAVID PUBLISHING
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It is noticed that most influenza A viruses remained resistant to amantadine and rimantadine with a high degree of oseltamivir resistance (but zanamivir sensitivity) in the seasonal wave of infection with H1N1 [5] . Therefore, a constant improvement of new anti-influenza virus drugs active against resistant influenza viruses is constantly required.
As a folk medicine since 300 BC, bee propolis is used as a food supplement for maintenance or improvement of human health [6] . It is composed of resins (40%-55%), beeswax and fatty acids (20%-35%), essential oils (10%), pollen (5%) and other ingredients, such as minerals, vitamins and sugar.
The chemical arrangement of propolis is complex and in it, over 180 compounds were determined. Among them, the polyphenols are most significant [7] . Its chemical composition differs, depending on origin and local plant ecology. Propolis' pharmacological properties were accounted as anti-carcinogenic [8] ,
anti-inflammatory [9] and anti-microbial [10] . The antiviral activity against several viruses [11] was further shown, e.g., adenovirus [12] , HIV [13] , herpes simplex virus [14, 15] and anti-influenza activity [16, 17] both in vitro and in vivo. Human leukocyte interferon (HuIFN-αN3) is a multi-subtype protein showing antiviral, anti-proliferative, anti-tumor, radio-protective and anti-toxic activity. There are three main classes of IFNs, designated as Types I, II and III [18] . Type I includes IFN-α, IFN-β, IFN-δ, IFN-ε, IFN-ζ, IFN-κ, IFN-ν, IFN-τ, and IFN-ω. Type II is composed of a single cytokine, IFN-γ [19] . Types III is IFN-λ1, IFN-λ2, IFN-λ3 and IFN-λ4. Type I-and type III-IFNs with similar signal transduction systems stay linked to each other than type II-IFN [20] . It is applied to treat a variety of viral illnesses and cancers. Among viruses, there are influenza A and B being susceptible to low dosage of HuIFN-αN3 [21] [22] [23] . It is crucial to analyze the effectiveness of the combo of extract of propolis (EEP) and water-soluble propolis (WSP) (Greit 120) with HuIFN-αN3 and through this to improve their potential clinical usefulness.
The purpose of the performed experiments was to elucidate the anti-influenza activity against influenza viruses A and B, of the combos of WSP (Greit 120) and HuIFN-αN3 in vitro.
Materials and Methods

Cells and Viruses
LLC-MK2 cells were cultivated in the Eagle's medium with 10% fetal calf serum (FCS) and antibiotics. Influenza A and B viruses' different clinical isolates were from Virological Department of the Institute of Microbiology and Immunology of the Medical Faculty in Ljubljana (Slovenia).
Compounds Employed in the Experiments
The 10% WSP prepared from 30% WSP (Greit 120) was obtained from BNatural, Corbetta (Italy). And 10% EEP was from Medex D.o.o., Ljubljana (Slovenia). HuIFN-αN3 was from Institute of Immunology, Zagreb (Croatia). (1)
Inhibition of Influenza
Analysis of HuIFN-αN3 by RP-HPLC
The HuIFN-αN3 subtype composition was analyzed by reverse-phase high-performance liquid chromatography (RP-HPLC). Used HPLC column was Phenomenex, Aeris™ Peptide column 3.6 μm XB-C18, Table 1 . Temperature of the column was 40 °C. The absorbance was measured at 214 nm and 280 nm. HuIFN-αN3 species of different compositions separated agreeing to the fact that there is relative hydrophobic pattern using RP-HPLC [27, 28] .
The Detection of Pinocembrin and Galangin by RP-HPLC Method
In 10 Table 2 .
Statistical Analysis
The ID 50 based on the mean plaque number was calculated on the raw data of an in-triplicate assay by regression analysis using Probit (SPSS statistical software package), determining the concentration of drug required to reduce the number of plaques by 50%.
Statistical analysis of the experimental data was performed with a two-tailed Student's t-test for paired samples with a p = 0.05 as the smallest level of significance. Additive Effects of Water-Soluble Propolis (Greit 120) and Human Interferon Alfa (HuIFN-αN3) against Influenza Viruses in Vitro Table 2 The steps of the RP-HPLC detection of pinocembrin and galangin.
Step: Chromatography of pinocembrin and galangin step Time (min) Solvent A (%) Solvent C (%)  0  0  70  30  1  5  60  40  2  15  60  40  3  20  35  65  4  25  35  65  5  30  70  30  6  35  70  30 3. Results corresponding to 100% destruction, 75%, 50%, 25%, non-infected, respectively) [31] (Table 3) . with acetonitrile gradient is presented in Fig. 2B [32] .
RP-HPLC Analyses of Sendai Virus (Cantell
Quantity of Caffeic
The quantity of caffeic acid, crysin, pinocembrin and galangin in the experimental sample of 10% EEP was calculated in comparison to standards ( Fig. 2A) .
Therefore, Table 4 indicates the quantity of caffeic acid, crysin, pinocembrin and galangin in the 10% EEP.
Molecular Composition of WSP (Greit 120) Determined by HPLC-UV-ESI-MS 504971
Fig . 3 shows the HPLC-UV-ESI-MS504971 profile of WSP (Greit 120).
Additive Effects of Water-Soluble Propolis (Greit 120) and Human
Interferon Alfa (HuIFN-αN3) against Influenza Viruses in Vitro In Table 5 , the molecular composition of WSP (Greit 120) in a very precise way is shown.
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Antiviral Activity of Combinations of 10% EEP, 10% WSP (Greit 120) and HuIFN-αN3
The experiments were performed to analyze the anti-influenza activity of 10% WSP (Greit 120) and 10% EEP in combination with HuIFN-αN3 in various proportions (1:1, 1:2 and 2:1). Ribavirin alone was a control. The results in Table 6 showed that the best results for ID 50 were, when the combination of 10% WSP (Greit 120) and HuIFN-αN3 in ratio 1:2 was used (ID 50 12 ± 2 μg/mL for influenza A and 19 ± 6 μg/mL for influenza B). With 10% EEP and HuIFN-αN3, the best ratio was the same 1:2, where it was 22 ± 7 μg/mL for influenza A and 15 ± 4 μg/mL for influenza B (Table 7) .
Ribavirin ID 50 Index
Ribavirin ID 50 index was calculated to compare the ID 50 (antiviral activity) of WSP (Greit 120) or 10% EEP in combination with HuIFN-αN3 in ratios 1:1, 1:2 and 2:1 in comparison to ribavirin. The results are in Tables 8 and 9 and Figs. 4 and 5. The lower is, the better it is. The ratio 1:2 was still the best with WSP (Greit 120) in combination with HuIFN-αN3 (0.5 for influenza B and 0.6 for influenza A virus). With EEP in combination with HuIFN-αN3, the best was the same ratio 1:2 (0.7 for influenza B and 1.3 for influenza A virus). ID 50 = Concentration of sample needed to reduce the virus-induced CPE to 50%. 
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Discussion
The samples of very detailed analyzed WSP (Greit 120) (Table 4) viruses [39, 40] .
WSP (Greit 120) enhances the anti-influenza activity of HuIFN-αN3 in dose-dependent ratio via enhanced resistance 1 (Mx1) expression and MxA induction of influenza virus replication inhibition.
Conclusions
From the performed experimental study, the following conclusions may be drawn. The anti-influenza A and B activity of WSP (Greit 120) is ID 50 31 ± 0.9 μg/mL for influenza A virus and ID 50 29 ± 0.2 μg/mL for influenza B. It is bit lower, but comparable with ribavirin, having ID 50 20 ± 0.2 μg/mL for influenza A and ID 50 28 ± 0.4 μg/mL for influenza B.
Combining WSP (Greit 120) with HuIFN-αN3 in ratio 1:2 caused the highest increase of anti-influenza A and B viruses' activity in vitro.
Anti-influenza activity of the combination of WSP (Greit 120) with HuIFN-αN3 is higher against influenza B than against influenza A virus.
This new formulation of WSP (Greit 120) and HuIFN-αN3 showing better anti-influenza activity, will definitely improve its application in flu infections.
